Skip to main content
TipRanks
Go Ultimate75% OFF

Vericel (ATQP) Drug Pipeline

2 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Autologous Cultured Chondrocytes On Porcine Collagen Membrane, Bone Marrow StimulationArticular Cartilage Defect, Chondral DefectPhase IIINot Yet RecruitingA Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the AnkleApr 01, 2025
Microfracture, MaciArticular Cartilage Defect, Chondral Defect, Osteochondritis Dissecans (Ocd), Articular Cartilage Disorder Of KneePhase IIIRecruitingA Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the KneeApr 04, 2018―
Ixmyelocel-TIschemic Dilated Cardiomyopathy (Idcm)Phase IICompletedAn Efficacy, Safety and Tolerability Study of Ixmyelocel-T Administered Via Transendocardial Catheter-based Injections to Subjects With Heart Failure Due to Ischemic Dilated Cardiomyopathy (IDCM)Aug 20, 2012―
Ixmyelocel-TCritical Limb IschemiaPhase IIICompletedAn Efficacy and Safety Study of Ixmyelocel-T in Patients With Critical Limb Ischemia (CLI)Nov 30, 2011―
Ixmyelocel-T, Vehicle ControlDilated CardiomyopathyPhase IICompletedUse of Ixmyelocel-T (Formerly Catheter-based Cardiac Repair Cell [CRC]) Treatment in Patients With Heart Failure Due to Dilated CardiomyopathyNov 25, 2009―
Bone Repair Cells (Brcs), Autologous Bone GraftSingle Level Posterolateral Spinal Fusionphase1AndPhase2TerminatedUse of TRC Autologous Bone Marrow Cells in Posterolateral Lumbar Spine FusionNov 24, 2008―
Standard of Care, Ixmyelocel-TDilated CardiomyopathyPhase IICompletedUse of Ixmyelocel-T (Formerly Cardiac Repair Cell [CRC] Treatment) in Patients With Heart Failure Due to Dilated Cardiomyopathy (IMPACT-DCM)Oct 02, 2008―
Autologous Cultured Chondrocytes On Porcine Collagen Membrane, MicrofractureArticular Cartilage DefectPhase IIICompletedSuperiority of MACI® Versus Microfracture Treatment in Patients With Symptomatic Articular Cartilage Defects in the KneeJul 17, 2008―
Ixmyelocel-T, Standard Of Care OnlyOsteonecrosisPhase IIICompletedIxmyelocel-T Treatment of Patients With Osteonecrosis of the Femoral HeadJul 20, 2007―
Ixmyelocel-TPeripheral Arterial DiseasePhase IICompletedUse of Ixmyelocel-T (Formerly Vascular Repair Cells [VRC]) in Patients With Peripheral Arterial Disease to Treat Critical Limb IschemiaApr 30, 2007―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Vericel Corporation (DE:ATQP) have in its pipeline
Vericel DE:ATQP is currently developing the following drugs: Autologous Cultured Chondrocytes On Porcine Collagen Membrane, Bone Marrow Stimulation, Microfracture, Maci, Ixmyelocel-T, Ixmyelocel-T, Vehicle Control, Bone Repair Cells (Brcs), Autologous Bone Graft, Standard of Care, Ixmyelocel-T, Autologous Cultured Chondrocytes On Porcine Collagen Membrane, Microfracture, Ixmyelocel-T, Standard Of Care Only, Fracture Surgery, Cultured Bone Marrow Tissue, Carticel (Autologous Cultured Chondrocyte) Implantation. These drug candidates are in various stages of clinical development as the company works toward FDA approval.